TrialJAMA oncology2021

Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical Trial.

Ola Landgren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.